Registered Nurse in Franklin, GA Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Connie Lee Beardsley, R.N. Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2295 Nutt Rd, Franklin, GA 30217 Phone: 706-675-3936 |
Shamonica Dorsey, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1206 Franklin Pkwy, Franklin, GA 30217 Phone: 706-675-6399 |
Elizabeth Ann Reed, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1206 Franklin Pkwy, Franklin, GA 30217 Phone: 706-616-5921 |
News Archive
FDA warns about Ranitidine containing known carcinogen NDMA
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
New study in fruit flies offers clues to delay human aging
One of the few reliable ways to extend an organism's lifespan, be it a fruit fly or a mouse, is to restrict calorie intake. Now, a new study in fruit flies is helping to explain why such minimal diets are linked to longevity and offering clues to the effects of aging on stem cell behavior.
TGen/George Mason create strategic research alliance to benefit patients with cancer, life-threatening illnesses
The Translational Genomics Research Institute (TGen) and George Mason University today announced the creation of a strategic research alliance to benefit patients with cancer and other life-threatening illnesses.
Genentech submits ACTEMRA sBLA to FDA
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).
Risk for depression appears to be higher in first three months after stroke, study finds
During the first three months after stroke, the risk for depression was eight times higher than in a reference population of people without stroke, according to an article published online by JAMA Psychiatry.
› Verified 5 days ago